EPS Bio Technology (ROCO:4183) LT-Debt-to-Total-Asset: 0.18 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4183 EPS Bio Technology Corp ROCO:4183
63 GF Score
Price NT$14.80
GF Value NT$22.94
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is EPS Bio Technology LT-Debt-to-Total-Asset?

EPS Bio Technology ROCO:4183 63 LT-Debt-to-Total-Asset is 0.18 as of Dec. 2025. GuruFocus rates ROCO:4183 with a GF Score™ of 63/100 and a GF Value™ of NT$22.94 (Significantly Undervalued). The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. EPS Bio Technology's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.18.

EPS Bio Technology's long-term debt to total assets ratio declined from Dec. 2024 (0.19) to Dec. 2025 (0.18). It may suggest that EPS Bio Technology is progressively becoming less dependent on debt to grow their business.

EPS Bio Technology  (ROCO:4183) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

EPS Bio Technology LT-Debt-to-Total-Asset Related Terms

EPS Bio Technology LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for EPS Bio Technology's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EPS Bio Technology LT-Debt-to-Total-Asset Chart

EPS Bio Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.22 0.20 0.19 0.18

EPS Bio Technology Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.18 0.18 0.18 0.18
ROCO:4183
63GF Score
EPS Bio Technology Corp ROCO:4183
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EPS Bio Technology LT-Debt-to-Total-Asset Calculation

EPS Bio Technology's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=95.021/533.247
=0.18

EPS Bio Technology's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=95.021/533.247
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.18 mean?
EPS Bio Technology (ROCO:4183) has a LT-Debt-to-Total-Asset of 0.18 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on EPS Bio Technology and its competitors.
Is EPS Bio Technology's LT-Debt-to-Total-Asset too high?
EPS Bio Technology's current LT-Debt-to-Total-Asset is 0.18. Overall, EPS Bio Technology has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EPS Bio Technology's LT-Debt-to-Total-Asset compare to ABT and SYK?
EPS Bio Technology's LT-Debt-to-Total-Asset of 0.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on EPS Bio Technology and its competitors. EPS Bio Technology's current LT-Debt-to-Total-Asset is 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EPS Bio Technology stock overvalued right now?
Based on GuruFocus' analysis, EPS Bio Technology (ROCO:4183) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$22.94, compared to a current price of NT$14.80 — trading 35.5% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.18. EPS Bio Technology's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For EPS Bio Technology (ROCO:4183), the current LT-Debt-to-Total-Asset is 0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EPS Bio Technology (ROCO:4183) Overvalued in 2026?

Based on GuruFocus' analysis, EPS Bio Technology stock appears to be undervalued. The current stock price of NT$14.80 is trading 35.5% below its estimated GF Value™ of NT$22.94. GuruFocus considers EPS Bio Technology to be Significantly Undervalued.

Key valuation signals for ROCO:4183:

  • LT-Debt-to-Total-Asset: 0.18
  • GF Value™: NT$22.94 vs. price of NT$14.80 (35.5% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EPS Bio Technology Business Description

Address No. 8, R&D 3rd Road, Hsinchu Science Park, Hsinchu, TWN, 30076
EPS Bio Technology Corp operates in medical equipment manufacturing, international trade, intellectual property, and research, design, development, manufacture and sale of blood glucose measuring system and cirrhosis testing system. Its products include Test sheet and Glucose machine. Geographically it operates in Germany, Iran, Kingdom of Saudi Arabia, Switzerland, Las Vegas, and Others with majority of the revenue deriving from Germany.
63GF Score

Get the complete analysis for ROCO:4183

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$14.80
Price
NT$22.94
GF Value